Sofargen 1% crema - per ferite ustioni e piaghe 120 g

Product Description

Treatment useful for healing wounds, burns and sores.

Indications

Sofargen Cream is useful in the prophylaxis and local antibacterial treatment of infections in cases of:

• second and third degree burns;
• infected varicose ulcers and bedsores;
• infected dermatological conditions or those susceptible to superinfections.

Dosage and method of use

In cases of burns, Sofargen Cream should be applied as soon as possible. After quickly cleansing the injured areas, immediately spread a uniform layer of cream 2 or 3 mm thick on the burned surfaces. The cream can be used as a barrier. It can be applied either directly to the lesions, possibly with the aid of a sterile glove, or with a sterile gauze. The medication should be applied without interruption, once or twice a day, as long as there is no risk of infection and until complete healing, both in spontaneous and surgical repairs.
Each time the dressing is changed, thoroughly cleanse the wounds with water or saline solution using a shower or sponge. Be sure to promptly reapply the cream to any surfaces from which it has been inadvertently removed.
In other cases, such as varicose ulcers, bedsores, wounds, and dermatological conditions susceptible to infection, cleanse the injured area where necessary and apply a 2-3 mm thick layer of cream, following the same criteria described for the treatment of burns. The wound must always be kept completely covered by the dressing.
If a knee-high dressing is required, unroll 20-30 cm sections of a suitably long bandage, spread a generous layer of cream on them, reroll the soaked part, unroll another 20-30 cm and repeat the operation until the entire length of the bandage is completely soaked, then apply the required bandage.

Composition

Active ingredient: Micronized silver sulfadiazine 1 g.
Excipients: Stearyl alcohol; isopropyl myristate; propylene glycol; polyethylene glycol monostearate; polyoxyethylenesorbitan monolaurate; methyl-p-hydroxybenzoate; distilled water.

Contraindications

Do not use Sofargen Cream in case of hypersensitivity to the active ingredient or to any of the excipients.
Since sulfonamides may increase the risk of neonatal jaundice, the drug should not be used in women at the end of pregnancy, in premature babies, and in newborns in the first months of life.

Special warnings

The drug should be used with caution in the presence of hepatic or renal insufficiency. The use of the drug may be risky in subjects with manifest glucose-6-phosphate dehydrogenase deficiency, as hemolytic phenomena may occur. Prolonged use of the product may give rise to sensitization phenomena. In this case, treatment must be interrupted and appropriate therapeutic measures must be adopted.
The same applies in the case of superinfection by resistant microorganisms. In the treatment of burns involving a large area of ​​the body, serum sulfonamide concentrations may reach therapeutic levels in adults. Therefore, in these patients, it would be advisable to monitor serum levels, renal function, the presence of any sulfonamide crystals in the urine, and liver function, interrupting therapy if liver and/or kidney function are compromised. Furthermore, since propylene glycol, present as an excipient in the composition, can cause hyperosmolarity when the product is applied to large burned areas, serum osmolarity must be periodically monitored and, if necessary, treatment must be interrupted.

Pregnancy and breastfeeding

Since there are no comprehensive experimental data on the possible effects of the drug on the fetus, the drug should not be used during pregnancy and breastfeeding unless, in the doctor's opinion, its use is indispensable and essential for the pregnant woman.

Expiry and storage

Check the expiry date indicated on the package. The expiry date indicated on the package refers to the product in its intact packaging, stored correctly.
Caution: Do not use the medicine after the expiry date indicated on the package.

Format

120 g tube.